This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourcedmust be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:
This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography articles
This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
This article is within the scope of WikiProject France, a collaborative effort to improve the coverage of France on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.FranceWikipedia:WikiProject FranceTemplate:WikiProject FranceFrance articles
This article is within the scope of WikiProject Business, a collaborative effort to improve the coverage of business articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.BusinessWikipedia:WikiProject BusinessTemplate:WikiProject BusinessWikiProject Business articles
How to reconcile BLP and the very controversial topicedit
Latest comment: 3 years ago1 comment1 person in discussion
We've seen a number of distasteful IP edits today, all of which quite rightly reverted. They of course stem from the very controversial nature of the subject, as both AstraZeneca and its chief executives are quick becoming both extremely controversial and getting a lot of media attention. It's hardly an overstatement to say that their current business practice is increasingly coming under criticism for quite literally resulting in a lot of people dying (obviously not the intention in any way, but nevertheless a consequence). This is fast becoming what AstraZeneca and its chief executives are notable for, making it highly WP:DUE for the article, yet should be mentioned in a way respecting WP:BLP and WP:RS. It is also probably safer to discuss at talk first, which is why I start this rather than going WP:BOLD on such a sensitive issue. Jeppiz (talk) 22:35, 27 January 2021 (UTC)Reply
